Biotech Values

[ghmm]

BMRN Briefing Doc:

... plus the CK data

What did you think of the documents even being skeptical of this pointing out the decrease could be due to other factors including possibly harm (decrease muscle activity, disease progression). I didn't get to the BMRN part where/if they talk about it but on some calls I've heard them talk about reducations noted in their studies being supportive of benefit.